From the Department of Neurology, Heidelberg University Hospital, Germany (D.P., T.B., E.H., M. Kloss, I.W., C.G.-G.).
Department of Biology, Southern University of Science and Technology, Shenzhen, China (B.C.).
Stroke. 2019 Feb;50(2):298-304. doi: 10.1161/STROKEAHA.118.021856.
Background and Purpose- We sought to explore the effect of genetic imbalance on functional outcome after ischemic stroke (IS). Methods- Copy number variation was identified in high-density single-nucleotide polymorphism microarray data of IS patients from the CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) and SiGN (Stroke Genetics Network)/GISCOME (Genetics of Ischaemic Stroke Functional Outcome) networks. Genetic imbalance, defined as total number of protein-coding genes affected by copy number variations in an individual, was compared between patients with favorable (modified Rankin Scale score of 0-2) and unfavorable (modified Rankin Scale score of ≥3) outcome after 3 months. Subgroup analyses were confined to patients with imbalance affecting ohnologs-a class of dose-sensitive genes, or to those with imbalance not affecting ohnologs. The association of imbalance with outcome was analyzed by logistic regression analysis, adjusted for age, sex, stroke subtype, stroke severity, and ancestry. Results- The study sample comprised 816 CADISP patients (age 44.2±10.3 years) and 2498 SiGN/GISCOME patients (age 67.7±14.2 years). Outcome was unfavorable in 122 CADISP and 889 SiGN/GISCOME patients. Multivariate logistic regression analysis revealed that increased genetic imbalance was associated with less favorable outcome in both samples (CADISP: P=0.0007; odds ratio=0.89; 95% CI, 0.82-0.95 and SiGN/GISCOME: P=0.0036; odds ratio=0.94; 95% CI, 0.91-0.98). The association was independent of age, sex, stroke severity on admission, stroke subtype, and ancestry. On subgroup analysis, imbalance affecting ohnologs was associated with outcome (CADISP: odds ratio=0.88; 95% CI, 0.80-0.95 and SiGN/GISCOME: odds ratio=0.93; 95% CI, 0.89-0.98) whereas imbalance without ohnologs lacked such an association. Conclusions- Increased genetic imbalance was associated with poorer functional outcome after IS in both study populations. Subgroup analysis revealed that this association was driven by presence of ohnologs in the respective copy number variations, suggesting a causal role of the deleterious effects of genetic imbalance.
背景与目的-我们旨在探讨遗传失衡对缺血性卒中(IS)后功能结局的影响。方法-在 CADISP(颈内动脉夹层和缺血性卒中患者)和 SiGN(卒中遗传学网络)/GISCOME(缺血性卒中功能结局遗传学)网络中,对 IS 患者的高密度单核苷酸多态性微阵列数据进行拷贝数变异识别。个体受拷贝数变异影响的蛋白编码基因总数定义为遗传失衡,将其与 3 个月后预后良好(改良 Rankin 量表评分 0-2)和预后不良(改良 Rankin 量表评分≥3)的患者进行比较。亚组分析仅限于受失衡影响的同系物的患者(一类剂量敏感基因),或受失衡不影响同系物的患者。通过逻辑回归分析,调整年龄、性别、卒中亚型、卒中严重程度和祖源,对失衡与结局的相关性进行分析。结果-本研究样本包括 816 名 CADISP 患者(年龄 44.2±10.3 岁)和 2498 名 SiGN/GISCOME 患者(年龄 67.7±14.2 岁)。122 名 CADISP 和 889 名 SiGN/GISCOME 患者的结局不良。多变量逻辑回归分析显示,两个样本中遗传失衡增加与预后不良相关(CADISP:P=0.0007;比值比=0.89;95%可信区间,0.82-0.95 和 SiGN/GISCOME:P=0.0036;比值比=0.94;95%可信区间,0.91-0.98)。该关联独立于年龄、性别、入院时的卒中严重程度、卒中亚型和祖源。亚组分析显示,影响同系物的失衡与结局相关(CADISP:比值比=0.88;95%可信区间,0.80-0.95 和 SiGN/GISCOME:比值比=0.93;95%可信区间,0.89-0.98),而无同系物的失衡则缺乏这种关联。结论-在两个研究人群中,遗传失衡增加与 IS 后功能结局不良相关。亚组分析显示,这种关联是由各自拷贝数变异中同系物的存在驱动的,提示遗传失衡的有害影响具有因果关系。